FedEx group to buy InPost for European out-of-home parcel network
A consortium of private investors led by FedEx on Monday reached an agreement on an all-cash offer to buy publicly traded InPost, a fast-growing express delivery firm based in Poland for 7.8 billion euros (equivalent to $9.2 billion) as FedEx moves to capture a larger share of the of the...
New Jaxport project to boost Toyota volumes
A new Vehicle Processing Center at The Port of Jacksonville, Fla., is expected to boost Toyota’s volumes at the maritime hub. The $145 million port project includes two state-of-the-art processing buildings with the addition of on-site rail connections and truck loading areas. The project...
White Paper: Why Some Mid-Market Fleets Will Win in 2026—and Others Won’t
Freight conditions may level out in 2026, but profitability will separate fast. Rising costs, tighter labor, and increasing compliance demands mean mid-market fleets can’t rely on market recovery to protect margin. This free strategic planning guide shows how disciplined operators are preparing...
Social Media Platforms Earn Billions from Scam Ads
Revolut claims social media sites make £3.8bn annually from scam ads targeting European users Continue reading →
Researchers Find 40,000+ Exposed OpenClaw Instances
SecurityScorecard has identified over 40,000 OpenClaw deployments exposed to potential attack Continue reading →
BridgePay Confirms Ransomware Attack, No Card Data Compromised
The services of Florida-based payments platform BridgePay are offline due to a ransomware attack Continue reading →
StockWatch: Better than Expected Q4 Lifts BMS Shares
Bristol Myers Squibb (NYSE: BMY; BMS) delivered some good news to investors in reporting fourth-quarter and full-year 2025 results on Thursday. The pharma giant beat analyst consensus forecasts by reporting higher than expected numbers for total revenue and its “growth” portfolio of drugs on...
Triple Negative Breast Cancer Cells Use ‘Sticky Coat’ to Support Clustering, Metastasis
The results of a preclinical study by researchers at Baylor College of Medicine have uncovered a strategy that triple negative breast cancer (TNBC) cells use to boost their ability to metastasize. Metastasis is the leading cause of cancer-related deaths and scientists are investigating ways to...
Hims cancels plans to sell compounded GLP-1 pill after FDA backlash
Following escalating legal threats from federal regulators regarding plans to sell an unapproved form of Novo Nordisk’s Wegovy pill, Hims said it “decided to stop offering access” to the treatment. Continue reading →